查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1804305

生物感應器的全球市場:各類型，各產品類型，各技術，各用途，各終端用戶，各地區 - 市場規模，產業趨勢，機會分析，預測(2025年～2033年)

Global Biosensors Market: By Type, Product Type, Technology, Application, End Users, Region- Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033
出版日期: | 出版商: Astute Analytica | 英文 342 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球生物感測器市場正經歷重大轉型期，這得益於技術進步和應用領域的不斷拓展，包括醫療保健、環境監測、農業和食品安全。預計該市場規模將在2024年達到321.5億美元，到2033年將達到758.4億美元，2025年至2033年間的複合年增長率將達到10.40%。

生物感測器在應對日益加重的慢性病負擔方面發揮關鍵作用。全球糖尿病患者超過4.22億，持續血糖監測系統已成為標準配置，其中雅培的FreeStyle Libre系統最為領先，在美國擁有400萬用戶。同樣，能夠在幾分鐘內檢測出心臟生物標記的生物感測器正在徹底改變心血管應用，從而加速治療和診斷。美國已有5800萬用戶採用了整合生物感測器的可穿戴設備，改善了緊急應變和患者預後。同時，與2020年相比，成本降低了35%，並且與智慧型手機相容，使生物感測器技術更加普及。

除了醫療保健領域，生物感測器還在推進環境安全，可在幾秒鐘內檢測出水污染物，並在食品安全方面取得進展，能夠在15分鐘內快速識別病原體。石墨烯奈米感測器和人工智慧診斷等技術創新正在提高各個領域的準確性、速度和整合能力。

值得關注的市場發展

  • Biolinq在C輪融資中籌集了1億美元，用於推進多分析生物感測器的開發。
  • DexCom 對 Oura Ring 的投資標誌著消費性穿戴裝置與血糖監測融合邁出了重要一步。
  • 美敦力和微軟 Azure 擴大了合作夥伴關係，利用生物感測器數據進行即時心臟風險分析。
  • 美國國家科學基金會 (NSF) 向賓州州立大學頒發了 150 萬美元獎金，用於生物感測器創新。
  • Trinity Biotech 和拜耳合作開發適用於印度和中國的連續血糖監測 (CGM)。
  • 荷蘭皇家飛利浦和 SmartQare 正在合作開發一套持續遠端監測系統。
  • 安德森生物科技公司獲得 360 萬美元融資，用於擴展其基於感測器的健康技術。
  • 瑞典新創公司 Aligned Bio 獲得了歐盟支持的種子輪融資，用於其單分子生物感測器平台的研發。

關鍵成長動力

即時診斷的擴展

醫療保健的去中心化正在推動生物感測器的應用，68% 的醫療保健提供者正在投資基於生物感測器的診斷技術，以縮短週轉時間。從流感檢測（現在只需 12 分鐘即可完成）到心肌肌鈣蛋白檢測（從 6 小時縮短至 10 分鐘），對即時結果的迫切需求正在重塑全球醫療保健工作流程。

微型化，實現持續監測

尺寸小於 0.5 毫米的可植入生物感測器市場正在蓬勃發展，這些感測器能夠即時追蹤體內的生物標記。經 FDA 批准的設備，例如雅培的植入式連續血糖監測 (CGM) 和美敦力的心律不整檢測器，已被證明可以顯著減少緊急住院治療。石墨烯和邊緣運算正在為預測分析和早期幹預奠定基礎。

新興科技趨勢

  • 石墨烯生物感測器目前可偵測濃度為 0.001 ng/mL 的癌症標記物，比傳統檢測方法快 85%。
  • 整合人工智慧後，診斷準確率提高了 18%，可識別出 92% 的先前未檢測到的病例。
  • 亞太地區在生物感測器應用方面處於領先地位，印度和中國等國家正在迅速擴大連續血糖監測 (CGM) 和即時診斷系統的部署，尤其是在農村地區和老齡化社會。
  • 農業技術領域也湧現許多技術創新，中國有 180 萬個農場使用生物感測器進行土壤和農藥監測。

本報告分析了全球生物感測器市場，提供了每個細分市場的市場規模和預測、市場動態和趨勢以及公司概況。

目錄

第1章 調查架構

  • 調查目的
  • 產品概要
  • 市場區隔

第2章 調查手法

第3章 摘要整理:全球生物感應器市場

第4章 全球生物感應器市場概要

  • 產業價值鏈分析
    • 材料供應商
    • 廠商
    • 批發商
    • 終端用戶
  • 產業預測
    • 慢性疾病發生統計
    • 電力診斷設備的進出口資料
  • 大環境分析
  • 波特的五力分析
  • 市場動態和趨勢
    • 成長促進因素
    • 阻礙因素
    • 課題
    • 主要趨勢
  • 市場成長及預測
    • 市場收益的估計與預測(2020年～2033年)
    • 市場規模的估計與預測(2020年～2033年)
    • 價格趨勢的分析
  • 競爭儀表板
    • 市場集中率
    • 企業的市場佔有率分析(金額)(2024年)
    • 競爭製圖

第5章 全球酵素為基礎的生物感應器市場概要

    • 各酵素類型
    • 各用途

第6章 全球生物感應器市場分析:各類型

  • 重要的知識見解
  • 市場規模與預測(2020年～2033年)
    • 感測器貼片
    • 嵌入式設備

第7章 全球生物感應器市場分析:各產品

  • 重要的知識見解
  • 市場規模與預測(2020年～2033年)
    • 穿戴式生物感應器
    • 非穿戴式生物感應器

第8章 全球生物感應器市場分析:各技術

  • 重要的知識見解
  • 市場規模與預測(2020年～2033年)
    • 電化學
    • 物理學
    • 光學

第9章 全球生物感應器市場分析:各用途

  • 重要的知識見解
  • 市場規模與預測(2020年～2033年)
    • 醫療
    • 食品毒性
    • 生物反應器
    • 農業
    • 環境
    • 研究開發
    • 保全·生化防禦
    • 其他

第10章 生物感應器市場分析:各終端用戶

  • 重要的知識見解
  • 市場規模與預測(2020年～2033年)
    • 醫療·診斷
    • 食品·飲料
    • 製藥
    • 農業
    • 化妝品
    • 環境
    • 其他

第11章 全球生物感應器市場分析:各地區

  • 重要的知識見解
  • 市場規模與預測(2019年～2032年)
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第12章 北美的生物感應器市場分析

  • 重要的知識見解
  • 市場規模與預測(2020年～2033年)
    • 各類型
    • 各產品
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國

第13章 歐洲的生物感應器市場分析

  • 重要的知識見解
  • 市場規模與預測(2020年～2033年)
    • 各類型
    • 各產品
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國

第14章 亞太地區的生物感應器市場分析

  • 重要的知識見解
  • 市場規模與預測(2020年～2033年)
    • 各類型
    • 各產品
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國

第15章 中東·非洲的生物感應器市場分析

  • 重要的知識見解
  • 市場規模與預測(2020年～2033年)
    • 各類型
    • 各產品
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國

第16章 南美的生物感應器市場分析

  • 重要的知識見解
  • 市場規模與預測(2020年～2033年)
    • 各類型
    • 各產品
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國

第17章 企業簡介(企業概要，財務矩陣，主要的產品的形勢，主要人員，主要的競爭，聯絡處，事業策略預測)

  • 生物感應器廠商
    • Bio-Rad Laboratories Inc.
    • Biosensors International Group, Ltd.
    • Pinnacle Technologies Inc.
    • Johnson & Johnson
    • Koninklijke Philips N.V.
    • DuPont
    • Molecular Devices Corp.
    • Bayer
    • Molex LLC
    • TDK Corp.
    • Seimens
    • Nova Biomedical
    • LifeScan, Inc.
    • 其他的著名的企業
  • 酵素生物感應器廠商
    • Medtronic
    • Abbott Laboratories
    • Roche
    • DirectSens GmbH
    • Zimmer & Peacock AS
    • 其他的著名的企業

第18章 附錄

簡介目錄
Product Code: AA04251266

The global biosensors market is undergoing a significant transformation, fueled by technological advancements and expanding applications across healthcare, environmental monitoring, agriculture, and food safety. Valued at US$ 32.15 billion in 2024, the market is expected to reach US$ 75.84 billion by 2033, reflecting a strong CAGR of 10.40% over the forecast period of 2025-2033.

Biosensors are playing a pivotal role in addressing the growing burden of chronic diseases. With over 422 million people worldwide living with diabetes, continuous glucose monitoring systems have become standard practice, notably Abbott's FreeStyle Libre, which serves 4 million users in the U.S. Similarly, cardiovascular applications are witnessing a revolution through biosensors capable of detecting cardiac biomarkers within minutes, expediting treatment and diagnosis. The adoption of biosensor-integrated wearables among 58 million U.S. users is improving emergency responsiveness and patient outcomes, while cost reductions of 35% since 2020 and smartphone compatibility have made biosensor technologies more accessible.

Beyond healthcare, biosensors are making headway in environmental safety-detecting water contaminants in seconds-and in food safety, where rapid pathogen identification now takes under 15 minutes. Innovations such as graphene-based nanosensors and AI-driven diagnostics are enhancing accuracy, speed, and integration capabilities across sectors.

Noteworthy Market Developments

  • Biolinq raised $100 million in Series C to advance multi-analyte biosensor development.
  • DexCom's investment in Oura Ring marks a major step toward merging consumer wearables with glucose monitoring.
  • Medtronic and Microsoft Azure extended their partnership for real-time cardiac risk analytics via biosensor data.
  • The U.S. NSF awarded $1.5 million to Penn State for biosensor innovation.
  • Trinity Biotech and Bayer partnered to develop CGMs for India and China.
  • Royal Philips and SmartQare co-developing continuous remote monitoring systems.
  • Andson Biotech secured $3.6 million to expand sensor-based health technologies.
  • Aligned Bio, a Swedish startup, attracted EU-backed seed funding for single-molecule biosensor platforms.

Core Growth Drivers

Point-of-Care Diagnostics Expansion:

The decentralization of healthcare is propelling biosensor deployment, with 68% of healthcare providers investing in biosensor-based diagnostics to reduce turnaround times. From flu testing (now done in 12 minutes) to cardiac troponin detection (from 6 hours to 10 minutes), the urgency for immediate results is reshaping medical workflows globally.

Miniaturization for Continuous Monitoring:

The market is witnessing a surge in implantable biosensors under 0.5 mm in size, allowing real-time tracking of internal biomarkers. FDA-approved devices like Abbott's implantable CGM and Medtronic's arrhythmia detectors are proving to significantly reduce emergency hospitalizations. Graphene and edge computing are setting the stage for predictive analytics and early intervention.

Emerging Technology Trends

  • Graphene biosensors now detect cancer markers at 0.001 ng/mL-85% faster than conventional tests.
  • AI integration is improving diagnostic accuracy by 18%, identifying 92% of previously undetected cases.
  • Asia-Pacific leads in biosensor adoption, especially in rural and aging populations, with countries like India and China rapidly expanding CGM and point-of-care deployment.
  • Innovations are also emerging in agri-tech, with 1.8 million farms in China using biosensors for soil and pesticide monitoring.

Barriers to Optimization

Regulatory Bottlenecks:

Stringent global regulatory frameworks continue to delay biosensor commercialization. In the U.S., average FDA approval timelines have lengthened to 17 months, while Europe's MDR mandates extended post-market surveillance. Additional burdens include mandatory in-country trials in China and cybersecurity regulations. Startups often face budgetary constraints, spending up to 35% of resources on trial redesigns due to changing ISO requirements.

Detailed Market Segmentation

By Technology:

Electrochemical biosensors dominate with over 71% market share in 2025. Used across diabetes management (CGMs), cardiovascular diagnostics (troponin-I), environmental monitoring (lead detection), and pharma R&D, their accuracy and adaptability make them the cornerstone of biosensor adoption. Platforms like Siemens Healthineers' S100 sepsis detector and India's $20 TB detection chips exemplify their utility.

By End Users:

Healthcare laboratories and clinics account for 51.7% of the market. Adoption of biosensors for EGFR, PD-L1, MRSA, VRE, and rapid sepsis detection is on the rise. India's Ayushman Bharat initiative and the CLIA-waived U.S. primary care mandate are key growth enablers.

By Type:

Embedded biosensors lead with 72.47% share, favored in dialysis systems, insulin pumps, and biopharma QA. Applications in RPM, telemedicine, automotive safety (e.g., alcohol sensors), and Industry 4.0 manufacturing underline their expansive integration.

By Product Type:

Non-wearable biosensors constitute 60.08% of the market, driven by their accuracy in clinical settings-blood-gas analyzers, cardiac monitors, pregnancy tests, and food safety detectors like ATP swabs. Their precision remains unmatched in critical care and regulated environments.

Geographic Insights

North America

North America dominates with 44.61% share, led by the U.S., which alone contributed 41% in 2024. With a strong R&D pipeline, widespread CGM adoption, and a booming wearables sector, the U.S. biosensors market continues to flourish. Key growth areas include POC testing, chronic disease monitoring, and venture-backed startups like Biolinq.

Europe

Europe contributes 28.3% to global revenue. EMA's proactive stance and funding programs like Horizon Europe and Health Innovation 2030 are fueling AI-driven sensor innovation. Countries such as Germany, France, and the U.K. are pioneering advanced biosensor trials and integration into public health frameworks.

Asia-Pacific

The region holds 19.8% share and is growing rapidly. CGM sales in China and India are spiking due to high diabetes prevalence. Government programs like Ayushman Bharat and NMPA's rapid approvals are facilitating rural and urban market penetration. Startups in Vietnam and Indonesia are spearheading affordable diagnostics.

Leading Market Participants

  • Bio-Rad Laboratories Inc.
  • Biosensors International Group, Ltd.
  • Pinnacle Technologies Inc.
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • DuPont
  • Molecular Devices Corp.
  • Bayer
  • Molex LLC
  • TDK Corp.
  • Seimens
  • Nova Biomedical
  • LifeScan, Inc.
  • Medtronic
  • Abbott Laboratories
  • Roche
  • DirectSens GmbH
  • Zimmer & Peacock AS
  • Other Prominent Players

Comprehensive Segmentation Framework

By Type

  • Sensor Patch
  • Embedded Device

By Product

  • Wearable Biosensors
  • Non-Wearable Biosensors

By Technology

  • Electrochemical
  • Amperometric
  • Potentiometric
  • Voltammetric
  • Others
  • Physical
  • Piezoelectric
  • Thermometric
  • Optical

By Application

  • Medical
  • POC Testing
  • Cholesterol
  • Blood Glucose
  • Blood Gas Analyzer
  • Pregnancy Testing
  • Drug Discovery
  • Infectious Disease
  • Bioreactor
  • Agriculture
  • Environment
  • Research & Development
  • Security and Bio-Defense
  • Others

By End User

  • Healthcare & Diagnostics
  • Food and Beverage
  • Pharmaceutical
  • Agriculture
  • Cosmetics
  • Environmental
  • Others

By Region:

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia & New Zealand
  • ASEAN
  • Cambodia
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Table of Content

Chapter 1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

Chapter 2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
  • 2.4. Assumption for the Study
  • 2.5. Market Size Estimation
  • 2.6. Data Triangulation

Chapter 3. Executive Summary: Global Biosensor Market

Chapter 4. Global Biosensor Market Overview

  • 4.1. Industry Value Chain Analysis
    • 4.1.1. Material Provider
    • 4.1.2. Manufacturer
    • 4.1.3. Distributor
    • 4.1.4. End User
  • 4.2. Industry Outlook
    • 4.2.1. Chronic Disease Incidence Statistics
    • 4.2.2. Electro-diagnostic Devices EXIM Data
  • 4.3. PESTLE Analysis
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers
    • 4.4.2. Bargaining Power of Buyers
    • 4.4.3. Threat of Substitutes
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Degree of Competition
  • 4.5. Market Dynamics and Trends
    • 4.5.1. Growth Drivers
    • 4.5.2. Restraints
    • 4.5.3. Challenges
    • 4.5.4. Key Trends
  • 4.6. Market Growth and Outlook
    • 4.6.1. Market Revenue Estimates and Forecast (US$ Bn), 2020-2033
    • 4.6.2. Market Volume Estimates and Forecast (Bn Units), 2020-2033
    • 4.6.3. Price Trend Analysis
  • 4.7. Competition Dashboard
    • 4.7.1. Market Concentration Rate
    • 4.7.2. Company Market Share Analysis (Value %), 2024
    • 4.7.3. Competitor Mapping

Chapter 5. Global Enzyme Based Biosensor Market Overview

    • 5.1.1. By Enzyme Type
      • 5.1.1.1. Key Insights
      • 5.1.1.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
        • 5.1.1.2.1. Oxidoreductases (e.g., glucose oxidase, lactate oxidase)
        • 5.1.1.2.2. Hydrolases (e.g., urease, cholinesterase)
        • 5.1.1.2.3. Transferases
        • 5.1.1.2.4. Lyases
    • 5.1.2. By Application
      • 5.1.2.1. Key Insights
      • 5.1.2.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
        • 5.1.2.2.1. Healthcare
          • 5.1.2.2.1.1. POC Testing
          • 5.1.2.2.1.2. Cholesterol
          • 5.1.2.2.1.3. Blood Glucose
          • 5.1.2.2.1.4. Blood Gas Analyzer
          • 5.1.2.2.1.5. Pregnancy Testing
          • 5.1.2.2.1.6. Drug Discovery
          • 5.1.2.2.1.7. Infectious Disease
          • 5.1.2.2.1.8. Cancer Biomarker Detection
        • 5.1.2.2.2. Cosmetics
          • 5.1.2.2.2.1. Enzyme-based skincare products
          • 5.1.2.2.2.2. Anti-aging formulations

Chapter 6. Global Biosensor Market Analysis, By Type

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 6.2.1. Sensor Patch
    • 6.2.2. Embedded Device

Chapter 7. Global Biosensor Market Analysis, By Product

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 7.2.1. Wearable Biosensors
    • 7.2.2. Non-Wearable Biosensors

Chapter 8. Global Biosensor Market Analysis, By Technology

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 8.2.1. Electrochemical
      • 8.2.1.1. Amperometric
      • 8.2.1.2. Potentiometric
      • 8.2.1.3. Voltammetric
      • 8.2.1.4. Others
    • 8.2.2. Physical
      • 8.2.2.1. Piezoelectric
      • 8.2.2.2. Thermometric
    • 8.2.3. Optical

Chapter 9. Global Biosensor Market Analysis, By Application

  • 9.1. Key Insights
  • 9.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 9.2.1. Medical
      • 9.2.1.1. POC Testing
      • 9.2.1.2. Cholesterol
      • 9.2.1.3. Blood Glucose
      • 9.2.1.4. Blood Gas Analyzer
      • 9.2.1.5. Pregnancy Testing
      • 9.2.1.6. Drug Discovery
      • 9.2.1.7. Infectious Disease
    • 9.2.2. Food Toxicity
    • 9.2.3. Bioreactor
    • 9.2.4. Agriculture
    • 9.2.5. Environment
    • 9.2.6. Research & Development
    • 9.2.7. Security and Bio-Defense
    • 9.2.8. Others

Chapter 10. Global Biosensor Market Analysis, By End User

  • 10.1. Key Insights
  • 10.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 10.2.1. Healthcare & Diagnostics
    • 10.2.2. Food and Beverage
    • 10.2.3. Pharmaceutical
    • 10.2.4. Agriculture
    • 10.2.5. Cosmetics
    • 10.2.6. Environmental
    • 10.2.7. Others

Chapter 11. Global Biosensor Market Analysis, By Region

  • 11.1. Key Insights
  • 11.2. Market Size and Forecast, 2019 - 2032 (US$ Bn & Bn Units)
    • 11.2.1. North America
      • 11.2.1.1. The U.S.
      • 11.2.1.2. Canada
      • 11.2.1.3. Mexico
    • 11.2.2. Europe
      • 11.2.2.1. Western Europe
        • 11.2.2.1.1. The UK
        • 11.2.2.1.2. Germany
        • 11.2.2.1.3. France
        • 11.2.2.1.4. Italy
        • 11.2.2.1.5. Spain
        • 11.2.2.1.6. Rest of Western Europe
      • 11.2.2.2. Eastern Europe
        • 11.2.2.2.1. Poland
        • 11.2.2.2.2. Russia
        • 11.2.2.2.3. Rest of Eastern Europe
    • 11.2.3. Asia Pacific
      • 11.2.3.1. China
      • 11.2.3.2. India
      • 11.2.3.3. Japan
      • 11.2.3.4. South Korea
      • 11.2.3.5. Australia & New Zealand
      • 11.2.3.6. ASEAN
        • 11.2.3.6.1. Cambodia
        • 11.2.3.6.2. Indonesia
        • 11.2.3.6.3. Malaysia
        • 11.2.3.6.4. Philippines
        • 11.2.3.6.5. Singapore
        • 11.2.3.6.6. Thailand
        • 11.2.3.6.7. Vietnam
      • 11.2.3.7. Rest of Asia Pacific
    • 11.2.4. Middle East & Africa
      • 11.2.4.1. UAE
      • 11.2.4.2. Saudi Arabia
      • 11.2.4.3. South Africa
      • 11.2.4.4. Rest of MEA
    • 11.2.5. South America
      • 11.2.5.1. Argentina
      • 11.2.5.2. Brazil
      • 11.2.5.3. Rest of South America

Chapter 12. North America Biosensor Market Analysis

  • 12.1. Key Insights
  • 12.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 12.2.1. By Type
    • 12.2.2. By Product
    • 12.2.3. By Technology
    • 12.2.4. By Application
    • 12.2.5. By End User
    • 12.2.6. By Country

Chapter 13. Europe Biosensor Market Analysis

  • 13.1. Key Insights
  • 13.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 13.2.1. By Type
    • 13.2.2. By Product
    • 13.2.3. By Technology
    • 13.2.4. By Application
    • 13.2.5. By End User
    • 13.2.6. By Country

Chapter 14. Asia Pacific Biosensor Market Analysis

  • 14.1. Key Insights
  • 14.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 14.2.1. By Type
    • 14.2.2. By Product
    • 14.2.3. By Technology
    • 14.2.4. By Application
    • 14.2.5. By End User
    • 14.2.6. By Country

Chapter 15. Middle East & Africa Biosensor Market Analysis

  • 15.1. Key Insights
  • 15.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 15.2.1. By Type
    • 15.2.2. By Product
    • 15.2.3. By Technology
    • 15.2.4. By Application
    • 15.2.5. By End User
    • 15.2.6. By Country

Chapter 16. South America Biosensor Market Analysis

  • 16.1. Key Insights
  • 16.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 16.2.1. By Type
    • 16.2.2. By Product
    • 16.2.3. By Technology
    • 16.2.4. By Application
    • 16.2.5. By End User
    • 16.2.6. By Country

Chapter 17. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 17.1. Biosensor Manufacturers
    • 17.1.1. Bio-Rad Laboratories Inc.
    • 17.1.2. Biosensors International Group, Ltd.
    • 17.1.3. Pinnacle Technologies Inc.
    • 17.1.4. Johnson & Johnson
    • 17.1.5. Koninklijke Philips N.V.
    • 17.1.6. DuPont
    • 17.1.7. Molecular Devices Corp.
    • 17.1.8. Bayer
    • 17.1.9. Molex LLC
    • 17.1.10. TDK Corp.
    • 17.1.11. Seimens
    • 17.1.12. Nova Biomedical
    • 17.1.13. LifeScan, Inc.
    • 17.1.14. Other Prominent Players
  • 17.2. Enzyme Biosensors Manufacturers
    • 17.2.1. Medtronic
    • 17.2.2. Abbott Laboratories
    • 17.2.3. Roche
    • 17.2.4. DirectSens GmbH
    • 17.2.5. Zimmer & Peacock AS
    • 17.2.6. Other Prominent Players

Chapter 18. Annexure

  • 18.1. List of Secondary Sources
  • 18.2. Key Country Markets - Marco Economic Outlook/Indicators